Nano Miscellaneous
Market Cap
₹24 ₹24.00 Cr.
P/E
0.00
PEG = P/E ÷ 5yr forward EPS CAGR

The forward EPS CAGR is estimated individually for each company - factoring in its guidance, industry, and growth drivers - not generic rule-based projection.

  • Johnson Pharmacare
  • AG Universal
  • Amit Securities

FAQs on Johnson Pharmacare Ltd. Shareprice

Johnson Pharmacare has given lower returns compared to its competitors.
Johnson Pharmacare has grown at ~-37.48% over the last 2yrs while peers have grown at a median rate of -26.1%

Johnson Pharmacare is not expensive.
Latest PE of Johnson Pharmacare is 0, while 3 year average PE is 34.8.
Also latest EV/EBITDA of Johnson Pharmacare is 0.0 while 3yr average is 37.84.

Growth Table

  • Johnson Pharmacare Ltd.
  • AG Universal
  • Amit Securities

Balance Sheet

  • Johnson Pharmacare Ltd.
  • AG Universal
  • Amit Securities

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Johnson Pharmacare Ltd.
  • AG Universal
  • Amit Securities

Cash Flow

  • Johnson Pharmacare Ltd.
  • AG Universal
  • Amit Securities

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Johnson Pharmacare Ltd.
  • AG Universal
  • Amit Securities

Quarterly Results

  • Johnson Pharmacare Ltd.
  • AG Universal
  • Amit Securities

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Johnson Pharmacare Ltd. Financials

Johnson Pharmacare balance sheet is weak and might have solvency issues

Yes, The net debt of Johnson Pharmacare is increasing.
Latest net debt of Johnson Pharmacare is ₹21.32 Crs as of Mar-26.
This is greater than Mar-25 when it was ₹0.58 Crs.

The profit is oscillating.
The profit of Johnson Pharmacare is -₹0.58 Crs for Mar 2025, -₹0.2 Crs for Mar 2024 and -₹1.29 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Johnson Pharmacare latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Inventory, Accounts Receivable, Short Term Loans & Advances

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech